CIK: 1780851 - Address: C/O Adaptive Biotechnologies Corporation, 1165 Eastlake Avenue East, Seattle, WA 98109
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

3/8/22 21:00
3/7/22
ADPTAdaptive Biotechnologies CorpWAHealthBioPrdBiological Products, (No DiagRobins Harlan SWAOChief ScS.d-5412.010-5-1312D
11/19/21 16:59
11/17/21
ADPTAdaptive Biotechnologies CorpWAHealthBioPrdBiological Products, (No DiagRobins Harlan SWAOChief ScM.dm266.5504669D
11/19/21 16:59
11/17/21
ADPTAdaptive Biotechnologies CorpWAHealthBioPrdBiological Products, (No DiagRobins Harlan SWAOChief ScS.dm-12832.000-4-569D
10/21/21 21:00
10/19/21
ADPTAdaptive Biotechnologies CorpWAHealthBioPrdBiological Products, (No DiagRobins Harlan SWAOChief ScM.dm736.550111969D
10/21/21 21:00
10/19/21
ADPTAdaptive Biotechnologies CorpWAHealthBioPrdBiological Products, (No DiagRobins Harlan SWAOChief ScS.dm-37833.710-11-1469D
10/8/21 19:00
10/6/21
ADPTAdaptive Biotechnologies CorpWAHealthBioPrdBiological Products, (No DiagRobins Harlan SWAOChief ScM.dm746.320122069D
10/8/21 19:00
10/6/21
ADPTAdaptive Biotechnologies CorpWAHealthBioPrdBiological Products, (No DiagRobins Harlan SWAOChief ScS.dm-38532.950-12-1469D
9/15/21 19:51
9/13/21
ADPTAdaptive Biotechnologies CorpWAHealthBioPrdBiological Products, (No DiagRobins Harlan SWAOChief ScM.dm746.320122069D
9/15/21 19:51
9/13/21
ADPTAdaptive Biotechnologies CorpWAHealthBioPrdBiological Products, (No DiagRobins Harlan SWAOChief ScS.dm-43236.980-12-1469D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact